免疫学
免疫系统
自身免疫性疾病
干扰素调节因子
生物
先天免疫系统
内部收益率1
干扰素
发病机制
自身免疫
体内
获得性免疫系统
转录因子
基因
抗体
遗传学
作者
Bharati Matta,Song Su,Dan Li,Betsy J. Barnes
出处
期刊:Cytokine
[Elsevier BV]
日期:2017-10-01
卷期号:98: 15-26
被引量:23
标识
DOI:10.1016/j.cyto.2017.02.006
摘要
Interferon regulatory factors (IRFs) play critical roles in pathogen-induced innate immune responses and the subsequent induction of adaptive immune response. Dysregulation of IRF signaling is therefore thought to contribute to autoimmune disease pathogenesis. Indeed, numerous murine in vivo studies have documented protection from or enhanced susceptibility to particular autoimmune diseases in Irf-deficient mice. What has been lacking, however, is replication of these in vivo observations in primary immune cells from patients with autoimmune disease. These types of studies are essential as the majority of in vivo data support a protective role for IRFs in Irf-deficient mice, yet IRFs are often found to be overexpressed in patient immune cells. A significant body of work is beginning to emerge from both of these areas of study – mouse and human.
科研通智能强力驱动
Strongly Powered by AbleSci AI